Skip to main content
Signal8

Lushi Avner

SEC insider (Form 3/4/5 filer). CIK 0002033604. Director at Brainsway Ltd. (BWAY) and 1 other issuer. 2 reported Form 4/5 transactions since Sep 2024; latest on Feb 20, 2026. Located in RAMAT GAN, L3.

Companies Lushi Avner has filed insider reports for

  • Brainsway Ltd. (BWAY): Director
  • Silexion Therapeutics Corp (SLXN): Director
Lushi Avner profile photo

Lushi Avner

CIK: 0002033604

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

Brainsway Ltd. logo
BWAY

Brainsway Ltd.

Director
Silexion Therapeutics Corp logo
SLXN

Silexion Therapeutics Corp

Director

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • Silexion Therapeutics Corp logo
    SLXN

    Silexion Therapeutics Corp

    Feb 20, 2026
    Award
    Indirect
    9.1K shares-
  • Silexion Therapeutics Corp logo
    SLXN

    Silexion Therapeutics Corp

    Feb 9, 2025
    Award
    Indirect
    1.6K shares-

1-2 of 2